Symptom Severity according to the Presence of Depressive and Anxiety Symptoms among Patients with Head and Neck Cancer

두경부암 환자의 우울과 불안증상 유무에 따른 증상의 심각성

Kim, Hyun-Joo;Cho, Ok-Hee;Yoo, Yang-Sook

  • Received : 2016.01.26
  • Accepted : 2016.04.18
  • Published : 2016.04.30


Purpose: The purpose of this study was to compare symptom severity and the impact of presence of depressive and/or anxiety symptoms among patients with head and neck cancer (HNC). Methods: One hundred and fifteen patients diagnosed with HNC completed two questionnaires: Hospital Anxiety and Depression Scale (HADS) and the M. D. Anderson Symptom Inventory-Head and Neck Cancer (MDASI-HN). Results: Of the total sample, 55.6% reported depressive symptoms and 33% reported anxiety symptoms. Patients who reported either depressive or anxiety symptoms also had significantly more severe symptoms. The most severe symptom was dry mouth. Participants who were depressed reported that interference in the enjoyment of life due to symptoms was the most distressing whereas participants with anxiety reported symptom interference in work was of most concern. Of patients reporting moderate to severe symptoms, more than 60% reported depressive symptoms. Of patients reporting moderate to severe feelings of being distress and feeling sad, more than 70% reported anxiety symptoms. Conclusion: Patients with HNC reporting moderate to severe symptoms also report depressive and/or anxiety symptoms. The results suggest the need to develop an integrated nursing intervention of both physical and emotional symptoms for patients with HNC.


Head and neck neoplasms;Symptom;Depression;Anxiety


  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. A Cancer of Journal for Clinicians. 2011;61(2):69-90.
  2. Jung KW, Won YJ, Kong HJ, Oh CM, Cho HS, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Research and Treatment. 2015;47(2):127-41.
  3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers version 2.2013 [Internet]. Washington: National Comprehensive Cancer Network; 2013 [cited 2013 September 4]. Available from:
  4. Statistics Korea. Korean Statistical Information Service [Internet]. Seoul: Statistics Korea.2013 [cited 2015 May 27]. Available from:
  5. Haisfield-Wolfe ME, McGuire DB, Soeken K, Geiger-Brown J, De Forge BR. Prevalence and correlates of depression among patients with head and neck cancer: a systematic review of implications for research. Oncology Nursing Forum. 2009;36(3):E107-25.
  6. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, et al. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head & Neck. 2013;35(10):1490-8.
  7. Xiao C, Hanlon A, Zhang Q, Ang K, Rosenthal DI, Nguyen-Tan PF, et al. Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncology. 2013;49(4):360-6.
  8. McQuestion M, Fitch M, Howell D. The changed meaning of food: physical, social and emotional loss for patients having received radiation treatment for head and neck cancer. European Journal of Oncology of Nursing. 2011;15(2):145-51.
  9. Oskam IM, Verdonck-de Leeuw IM, Aaronson NK, Witte BI, de Bree R, Doornaert P, et al. Prospective evaluation of health-related quality of life in long-term oral and oropharyngeal cancer survivors and the perceived need for supportive care. Oral Oncology. 2013;49(5):443-8.
  10. Teunissen SC, de Graeff A, Voest EE, de Haes JC. Are anxiety and depressed mood related to physical symptom burden? a study in hospitalized advanced cancer patients. Palliative Medicine. 2007;21(4):341-6.
  11. Chen ML, Chang HK. Physical symptom profiles of depressed and nondepressed patients with cancer. Palliative Medicine. 2004;18(8):712-18.
  12. Gil F, Costa G, Hilker I, Benito L. First anxiety, afterwards depression: psychological distress in cancer patients at diagnosis and after medical treatment. stress and health 2012;28:362-7.
  13. Chiou WY, Lee MS, Ho HC, Hung SK, Lin HY, Su YC, et al. Prognosticators and the relationship of depression and quality of life in head and neck cancer. Indian Journal of Cancer. 2013; 50(1):14-20.
  14. Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M.D. Anderson symptom inventory, head and neck module. Head & Neck. 2007;29(10):923-31.
  15. Oh SM, Min KJ, Park DB. A study on the standardization of the Hospital Anxiety and Depression Scale for Koreans. Journal Korean Neuropsychiatric Association. 1999;38(2):289-96.
  16. Joseph LA, Routledge JA, Burns MP, Swindell R, Sykes AJ, Slevin NJ, et al. Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patients. The Journal of Laryngology & Otology. 2013;127(3):285-94.
  17. Krebber AM, Buffart LM, Kleijn G, Riepma IC, de Bree R, Leemans CR, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-oncology. 2014;23(2):121-30.
  18. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. Journal of Clinical Oncology. 1984:2(3):187-93.
  19. Lue BH, Huang TS, Chen HJ. Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy. International Journal of Radiation Oncology Biology Physics. 2008;70(1):28-34.
  20. Chen SC, Lai YH, Liao CT, Lin CC, Chang JT. Changes of symptoms and depression in oral cavity cancer patients receiving radiation therapy. Oral Oncology. 2010;46(7):509-13.
  21. Elting LS. Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head and neck malignancies. International Journal Radiation Oncology Biology Physics. 2007;68(4):1110-20.
  22. Keereweer S, Kerrebijn JDF, Al-Mamgani A, Sewnaik A, Baatenburg de Jong RJ, van Meerten E. Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life. European Archives of Otorhinolaryngology. 2012;269(3):939-46.
  23. Maurer J, Hipp M, Schafer C, Kolbl O. Dysphagia impact on quality of life after radio (chemo) therapy of head and neck cancer. Strahlentherapie und Onkologie. 2011;187(11):744-9
  24. So WKW, Chan RJ, Chan DN, Hughes BG, Chair SY, Choi KC, et al. Quality-of-life among head and neck cancer survivors at one year after treatment - a systematic review. European Journal of Cancer. 2012;48(15):2391-408.
  25. Karthikeyan G, Jumnani D, Prabhu R, Manoor UK, Supe SS. Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study. Indian Journal of Palliative Care. 2012;18(3):165-75.
  26. Oh PJ, Jung JA. A meta-analysis of intervention studies on cancer-related fatigue in Korea: 1990-2010. Journal of Korean Clinical Nursing Research. 2011;17(2):163-75.
  27. Reddy SK, Parsons HA, Elsayem A, Palmer JL, Bruera E. Characteristics and correlates of dyspnea in patients with advanced cancer. Journal of Palliative Medicine. 2009;12(1):29-36.
  28. Berkey FJ. Managing the adverse effects of radiation therapy. American Family Physician. 2010;82(4):381-8.
  29. Bornbaum CC, Fung K, Franklin JH, Nichols A, Yoo J, Doyle PC. A descriptive analysis of the relationship between quality of life and distress in individuals with head and neck cancer. Support Care Cancer. 2012;20(9):2157-65.
  30. Buchmann L, Conlee J, Hunt J, Agarwal J, White S. Psychosocial distress is prevalent in head and neck cancer patients. Laryngoscope. 2013;123(6):1424-9.